Nasal lymphoid tissue, intranasal immunization, and compartmentalization of the common mucosal immune system

Mestecky J: The common mucosal immune system and current strategies for immune response in external secretions. J Clin Immunol 1987;7:265–276.

Kanesaki T, Murphy BR, Collins PL, Ogra PL: Effectiveness of enteric immunization in the development of secretory immunoglobulin A response and the outcome of infection with respiratory syncytial virus. J Virol 1991;65: 657–663.

McGhee J, Mestecky J, Dertzbaugh MT, Eldridge JH, Hirasawa M, Kiyono H: The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 1992; 10:75–88.

Oien NL, Brideau RJ, Walsh EE, Wathen MW: Induction of local and systemic immunity against human respiratory syncytial virus using a chimeric FG glycoprotein and cholera toxin B subunit. Vaccine 1994;12:731–735.

Wu H-Y, Nahm M, Guo Y, Russell MW, Briles DE: Intranasal immunization of mice with PspA (pneumococcal surface protein A) can prevent intranasal carriage, pulmonary infection, and sepsis with Streptococcus pneumoniae. J Infect Dis 1997;175:839–846.

Walker RI: New strategies for using mucosal vaccination to achieve more effective immunization. Vaccine 1994; 12:387–400.

Russell MW, Lue C, van denWall Bake AWL, Moldoveanu Z Mestecky J: Molecular heterogeneity of human IgA antibodies during an immune response. Clin Exp Immunol 1992;87:1–6.

Meitin CA, Bender BS, Small PA: Enteric immunization of mice against influenza with recombinant vaccinia. Proc Natl Acad Sci USA 1994;91:11,187–11,191.

Offit PA, Dudzik KI: Rotavirusspecific cytotoxic T lymphocytes appear at the intestinal mucosal surface after rotavirus infection. J Virol 1989;63:3507–3512.

Chardès T, Velge-Roussel F, Mevelec P, Mevelec M-N, Buzoni-Gatel D, Bout D: Mucosal and systemic cellular immune responses induced byToxoplasma gondii antigens in cystorally infected mice. Immunology 1993;78:421–429.

Russell MW, Wu H-Y: Distribution, persistence, and recall of serum and salivary antibody responses to peroral immunization with protein antigen I/II ofStreptococcus mutans coupled to the cholera toxin B subunit. Infect Immun 1991;59:4061–4070.

Wu H-Y, Russell MW: Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit. Infect Immun 1993;61:314–322.

Haneberg B, Kendall D, Ameron-gen HM, Apter FM, Kraehenbuhl J-P, Neutra MR: Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina measured by a new method for collection of secre- tions from local mucosal sur- faces. Infect Immun 1994;62: 15–23.

Marx PA, Compans RW, Gettie A, Staas JK, Gilley RM, Mulligan MJ, Yamshchikov GV, Chen D, Eldridge JH: Protection against vaginal SIV transmission with microencapsulated vaccine. Science 1993;260:1323–1327.

Moldoveanu Z, Russell MW, Wu H-Y, Huang W-Q, Compans RW, Mestecky J: Compartmentalization within the common mucosal immune system. Adv Exp Med Biol 1995;371:97–101.

Dunkley M, Pabst R, Cripps A: An important role for intestinally derived T cells in respiratory defence. Immunol Today 1995; 16:231–236.

McGhee JR, Fujihashi K, Xu-Amano J, Jackson RJ, Elson CO, Beagley KW, Kiyono H: New perspectives in mucosal immunity with emphasis on vaccine development. Seminars Hematol 1993; 30:3–15.

Tamura S, Samegai Y, Kurata H, Kikuta K, Nagamine T, Aizawa C, Kurata T: Enhancement of protective antibody responses by cholera toxin B subunit inoculated intranasally with Influenza vaccine. Vaccine 1989;7:257–262.

Abraham E: Intranasal immuniza- tion with bacterial polysaccharide containing liposomes enhances antigen-specific pulmonary secretory antibody response. Vaccine 1992;10:461–468.

Langermann S, Palaszynski S, Sadziene A, Stover CK, Koenig S: Systemic and mucosal immunity induced by BCG vector expressing outer-surface protein A ofBorrelia burgdorferi. Nature 1994; 372:552–555.

Kuper CF, Koornstra PJ, Hameleers DMH, Biewenga J, Spit BJ, Duijvestijn AM, Vriesman PJCvB, Sminia T: The role of nasopharyngeal lymphoid tissue. Immunol Today 1992;13:219–224.

Brandtzaeg P, Halstensen TS: Immunology and immunopathology of tonsils. Adv Otorhinolaryngol 1992;47:64–75.

Koornstra P, J Duijvestijn AM, Vlek LFM, Marres EHMA, Vriesman PJCvB: Tonsillar (Waldeyer’s ring equivalent) lymphoid tissue in the rat: lymphocyte subset binding to high endothelial venules (HEV) and in situ distribution. Regional Immunol 1992;4:401–408.

Quiding-JÄrbrink M, Granström I, Holmgren J, Czerkinsky C: Induction of compartmentalized B-cell responses in human tonsils. Infect Immun 1995;63:853–857.

Wu H-Y, Nikolova EB, Beagley KW, Russell MW: Induction of antibody-secreting cells and T- helper and memory cells in murine nasal lymphoid tissue. Immunology 1996;88:493–500.

Shahin RD, Amsbaugh DF, Leef MF: Mucosal immunization with filamentous hemagglutinin protects againstBordetella pertussis respiratory infection. Infect Immun 1992;60:1482–1488.

Thapar MA, Parr EL, Parr MB: The effect of adjuvants on antibody titers in mouse vaginal fluid after intravaginal immunization. J Reproduct Immunol 1990;17: 207–216.

Thapar MA, Parr EL, Bozzola JJ, Parr MB: Secretory immune responses in the mouse vagina after parenteral or intravaginal immunization with an immuno- stimulating complex (ISCOM). Vaccine 1991;9:129–133.

Gallichan WS: Specific secretory immune responses in the female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B of herpes simplex virus. Vaccine 1995;13: 1589–1595.

Di Tommaso A, Saletti G, Pizza M, Rappuoli R, Dougan G, Abrig-nani S, Douce G, De Magistris MT: Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat- labile enterotoxin as a mucosal adjuvant. Infect Immun 1996;64: 974–979.

O’Hagan DT, Rafferty D, Wharton S, Illum L: Intravaginal immunization in sheep using a bioadhesive microsphere antigen delivery system. Vaccine 1993; 11:660–664.

O’Hagan DT, Rafferty D, Mckeating JA, Illum L: Vaginal immunization of rats with a synthetic peptide from human immunodeficiency virus envelope glycoprotein. J Gen Virol 1992;73:2141–2145.

Hirabayashi Y, Kurata H, Funato H, Nagamine T, Aizawa C, Tamura S, Shimada K, Kurata T: Comparison of intranasal inoculation of influenza HA vaccine combined with cholera toxin B subunit with oral or parenteral vaccination. Vaccine 1990;8:243–248.

Moldoveanu Z, Porter DC, Lu A, McPherson S, Morrow CD: Immune responses induced by administration of encapsidated poliovirus replicons which express HIV-1 gag and envelop proteins. Vaccine 1995;13:1013–1022.

Polly SM, Waldman RH, High P, Wittner MK, Dorfman A, Fox EN: Protective studies with a group A streptococcal M protein vaccine. II. Challenge of volunteers after local immunization in the upper respiratory tract. J Infect Dis 1975;131:217–224.

Gallichan WS, Johnson DC, Graham FL, Rosenthal KL: Mucosal immunity and protection after intranasal immunization with recombinant adenovirus expressing herpes simplex virus glycoprotein B. J Infect Dis 1993;168: 622–629.

Bessen D, Fischetti VA: Synthetic peptide vaccine against mucosal colonization by group A streptococci. I. Protection against a heterologous M serotype with shared C repeat region epitopes. J Immunol 1990;145:1251–1256.

Ray R, Glaze BJ, Moldoveanu Z, Compans RW: Intranasal immunization of hamsters with envelope glycoproteins of human parainfluenza virus type 3. J Infect Dis 1988;157:648–654.

Renegar KB, Small Jr PA: Immunoglobulin A mediation of murine nasal anti-influenza virus immunity. J Virol 1991;65:2146–2148.

Russell MW, Moldoveanu Z, White PL, Sibert GJ, Mestecky J, Michalek SM: Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the cholera toxin B subunit. Infect Immun 1996;64:1272–1283.

Takahashi I, Okahashi N, Matsushita K, Tokuda M, Kanamoto T, Munekata E, Russell MW, Koga T: Immunogenicity and protective effect against oral colonization byStreptococcus mutans of synthetic peptides of a streptococcal surface protein antigen. J Immunol 1991; 146:332–336.

Katz J, Harmon CC, Buckner GP, Richardson GJ, Russell MW, Michalek SM: Protective salivary immunoglobulin A responses againstStreptococcus mutans infection after intranasal immunization withS. mutans antigen I/II coupled to the B subunit of cholera toxin. Infect Immun 1993; 61:1964–1971.

Pal S, Peterson EM, de la Maza LM: Intranasal immunization induces long-term protection in mice against aChlamydia trachomatis genital challenge. Infect Immun 1996;64:5341–5348.

Perry ME, Brown KA, von Gau-deckerB: Ultrastructural identification and distribution of the adhesion molecules ICAM-1 and LFA-1 in the vascular and extravascular compartments of the human palatine tonsil. Cell Tissue Res 1992;268:317–326.

Finzi G, Cornaggia M, Capeila C, Fiocca R, Bosi F, Solcia E, Samloff IM: Cathepsin E in follicle associated epithelium of intestine and tonsils: localization to M cells and possible role in antigen processing. Histochemistry 1993;99:201–211.

Tang X, Hori S, Osamura RY, Tsutsumi Y: Reticular crypt epithelium and intra-epithelial lymphoid cells in the hyperplastic human palatine tonsil: an immunohistochemical analysis. Pathol Internat 1995;45:34–44.

Nicholson IC, Brisco MJ, Zola H: Memory B lymphocytes in human tonsil do not express surface IgD. J Immunol 1995;154:1105–1113.

Komai-Koma M, Liew FY, Wilkinson PC: Interactions between IL-4, anti-CD40, and anti-immunoglobulin as activators of locomotion of human B cells. J Immunol 1995;155:1110–1116.

Rodriguez C, Roldan E, Navas G, Brieva JA: Essential role of tumor necrosis factor-alpha in the differentiation of human tonsil in vivo induced B cells capable of spontaneous and high-rate immunoglobulin secretion. Eur J Immunol 1993;23:1160–1164.

Morente M, Piris MA, Orradre JL, Rivas C, Villuendas R: Human tonsil intraepithelial B cells: a marginal zone-related subpopulation. J Clin Pathol 1992;45:668–672.

Waldo FB, van denWall Bake AWL, Mestecky J, Husby S: Suppression of the immune response by nasal immunization. Clin Immunol Immunopathol 1994; 72:30–34.

Mowat AM: Oral tolerance and regulation of immunity to dietary antigens; in Ogra PL, Mestecky J, Lamm ME, Strober W, McGhee JR, Bienenstock J (eds): Handbook of Mucosal Immunology. San Diego, CA, Academic, 1994, pp 185–201.

Ma C-G, Zhang G-X, Xiao B-G, Link J, Olsson T, Link H: Suppression of experimental autoimmune my asthenia gravis by nasal administration of acetylcholine receptor. J Neuroimmunol 1995;58:51–60.

Miller A, Lider O, Roberts AB, Sporn MB, Weiner HL: Suppressor T cells generated by oral tolerization to myelin basic protein suppress bothin vitro andin vivo immune responses by the release of transforming growth factor Β after antigen-specific triggering. Proc Natl Acad Sci USA 1992;89:421–425.

Higgins PJ, Weiner HL: Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments. J Immunol 1988; 140:440–445.

Hameleers DMH, van derEndeM, Biewenga J, Sminia T: An immunohistochemical study on the postnatal development of rat nasal-associated lymphoid tissue (NALT). Cell Tissue Res 1989; 256:431–438.

van derVen I, Sminia T: The development and structure of mouse nasal-associated lymphoid tissue: an immuno- and enzyme-histo- chemical study. Regional Immunol 1993;5:69–75.

Wu H-Y, Nikolova EB, Beagley KW, Eldridge JH, Russell MW: Development of antibody-secreting cells and antigen-specific T cells in cervical lymph nodes after intranasal immunization. Infect Immun 1997;65:227–235.

Coffman RL, Seymour BW, Leb-man DA, Hiraki DD, Christiansen JA, Shrader B, Cherwinski MH, Savelkoul HF, Finkelman FD, Bond M. W., Mosmann TR: The role of helper T cell products in mouse B cell differentiation and isotype regulation. Immunol Rev 1988;102:5.

Parr EL, Parr MB, Thapar M: A comparison of specific antibody response in mouse vaginal fluid after immunization by several routes. J Reproduct Immunol 1988;14:165–172.

Snapper CM, Peschel A, Paul WE: IFN-γ stimulates IgG2a secretion by murine B cells stimulated with bacterial lipopolysaccharide. J Immunol 1988;140:2121.

Snapper CM, Finkelman FD, Paul WW: Regulation of IgGl and IgE production by interleukin 4. Immunol Rev 1988;102:51.

Reuman PD, Keely SP, Schiff GM: Rapid recovery in mice after combined nasal/oral immunization with killed respiratory syncytial virus. J Med Virol 1990; 32: 67–72.

Barbour ML, Mayon-White RT, Coles C, Crook DW, Moxon ER: The impact of conjugated vaccine on carriage ofHaemophilus infuenzae type b. J Infect Dis 1995;171:93–98.

Kurono Y, Shigemi H, Kodama S, Mogi G: Effects of oral and systemic immunization on nasopharyngeal clearance of nontypeableHaemophilus influenzae in BALB/c mice. Laryngoscope 1996; 106: 614–618.

Bessen D, Fischetti VA: Influence of intranasal immunization with synthetic peptides corresponding to conserved epitopes of M protein on mucosal colonization by group A streptococci. Infect Immun 1988;56:2666–2672.

Lehner T, Ma JK-C, Kelly CG: A mechanism of passive immuniza- tion with monoclonal antibodies to a 185,000 Mr streptococcal anti- gen; in Ciardi JE, McGhee JR, Keith J (ed): Genetically Engineered Vaccines: Prospects for Oral Disease Prevention. New York, Plenum, 1992, pp 151–163.

Moldoveanu Z, Clements ML, Prince SJ, Murphy BR, Mestecky J: Human immune responses to influenza virus vaccines adminis- tered by systemic or mucosal routes. Vaccine 1995;13:1006–1012.

Hajishengallis G, Nikolova E, Russell MW: Inhibition of Streptococcus mutans adherence to saliva-coated hydroxyapatite by human secretory immunoglobulin A (S-IgA) antibodies to cell surface protein antigen I/II: reversal by IgAl protease cleavage. Infect Immun 1992;60:5057–5064.

Magnusson K-E, Stjernström I: Mucosal barrier mechanisms. Interplay beween secretory IgA (S-IgA), IgG and mucins on the surface properties and association of salmonellae with intestine and granulocytes. Immunology 1982; 45:239.

Kilian M, Russell MW: Function of mucosal immunoglobulins; in Ogra PL, Mestecky J, Lamm ME, Strober W, McGhee JR, Bienenstock J (eds): Handbook of Mucosal Immunology. San Diego, CA, Academic, 1994, pp 127–137.

Wira CR, O’Mara B, Richardson J, Prabhala R: The mucosal immune system in the female reproductive tract: influence of sex hormones and cytokines on immune recognition and responses to antigen. Vaccine Res 1992;1: 151–167.

Prabhala RH, Wira CR: Sex hormone and IL-6 regulation of antigen presentation in the female reproductive tract mucosal tissues. J Immunol 1995; 155: 5566–5573.

Fidel Jr. PL, Lynch ME, Conaway DH, Tait L, Sobel JD: Mice immunized by primary vaginalCandida albicans infection develop acquired vaginal mucosal immunity. Infect Immun 1995;63:547–553.

Shahin R, Leef M, Eldridge J, Hudson M, Gilley R: Adjuvanticity and protective immunity elicited byBordetella pertussis antigens encapsulated in poly(DL-lactideco-glycolide) microspheres. Infect Immun 1995;63:1195–1120.

Muller CP, Beauverger P, Schneider F, Jung F, Brons NH: Cholera toxin B stimulates systemic neutralizing antibodies after intranasal coimmunization with measles virus. J Gen Virol 1995;76:1371–1380.

Lowell GH, Kaminski RW, Grate S, Hunt RE, Charney C, Zimmer S, Colleton C: Intranasal and intramuscular proteosome-staphylococal enterotoxin B (SEB) toxoid vaccines: immunogenicity and efficacy against lethal SEB intoxi- cation in mice. Infect Immun 1996; 64:1706–1713.

Fishman-Lobell J, Friedman A, Weiner HL: Different kinetic patterns of cytokine gene expression in vivo in orally tolerant mice. Eur J Immunol 1994;24:2720- 2724.

Husby S, Mestecky J, Moldo-veanu Z, Holland S, Elson CO: Oral tolerance in humans. J Immunol 1994;152:4663–4670.

Brandtzaeg P: History of oral tolerance and mucosal immunity. Ann NY Acad Sci 1996;778:1–27.

Melamed D, Fishman-Lobell J, Uni Z, Friedman A: Peripheral tolerance of Th2 lymphocytes induced by continuous feeding of ovalbumin. Internat Immunol 1996;8:717–724.

Khoury SJ, Hancock WW, Weiner HL: Oral tolerance to myelin basic protein and natural encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor, interleukin 4, and prostaglandin E expression in the brain. J Exp Med 1992; 176:1355–1364.

Gilbert KM, Hoang KD, Weigle WO: Th1 and Th2 clones differ in their response to tolerogenic signal. J Immunol 1990; 144:2063.

Duchmann R, Schmitt E, Knolle P, Zum Büshenfelde KHM: Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12. Eur J Immunol 1996;26:934–938.

Lipscombe M, Charles IG, Roberts M, Dougan G, Tite J, Fairweather NF: Intranasal immunization using the B-subunit of theEscherichia coli heat-labile toxin fused to an epitope of theBordetella pertus- sis P.69 antigen. Mol Microbiol 1991;5:1385–1392.

Borein B:The iscom: an immunostimulating system. Immunol Lett 1990;25:281–283.

Aramaki Y, Fujii Y, Yachi K, Kikuchi H, Tsuchiya S: Activation of systemic and mucosal immune response following nasal admin- istration of liposomes. Vaccine 1994; 12:1241–1245.

Corrigan CJ, Kay AB: T cells and eosinophils in the pathogenesis of asthma. Immunol Today 1992; 13:501–506.